• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清中III型胶原蛋白的N端前肽反映了慢性肝病患者的纤维化活动和程度。

The N-terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease.

作者信息

Frei A, Zimmermann A, Weigand K

出版信息

Hepatology. 1984 Sep-Oct;4(5):830-4. doi: 10.1002/hep.1840040505.

DOI:10.1002/hep.1840040505
PMID:6479851
Abstract

To evaluate the diagnostic significance of the collagen Type III (Col 1-3) N-terminal propeptide of procollagen Type III, with respect to activity and degree of liver fibrosis, Col 1-3 serum concentrations were measured in 111 patients with chronic liver diseases and in 60 patients were correlated with liver histology and morphometry. Col 1-3 was measured by a specific radioimmunoassay. Biopsies were read without knowledge of diagnosis. Periportal and intralobular lesions were assessed semiquantitatively by allocating 1 of 4 severity grades to each parameter. All portal areas were measured morphometrically. Compared to 27 normal controls, Col 1-3 concentrations were significantly elevated in patients with untreated chronic active hepatitis, cirrhosis and primary biliary cirrhosis, but not in chronic persistent hepatitis or fatty liver. Morphometrically measured portal tract area significantly correlated with Col 1-3 plasma levels. Among the semiquantitatively measured periportal lesions, the number of fibroblasts exhibited the closest relationship with Col 1-3 levels; there was no relationship between Col 1-3 levels and intralobular lesions. These data suggest that Col 1-3 serum levels reliably reflect the activity and degree of liver fibrosis and are useful along with liver biopsy in follow-up of patients with chronic liver disease.

摘要

为评估Ⅲ型前胶原N端前肽(Col 1-3)对肝纤维化活动度和程度的诊断意义,对111例慢性肝病患者和60例对照者检测血清Col 1-3浓度,并与肝组织学和形态计量学结果进行相关性分析。采用特异性放射免疫分析法检测Col 1-3。肝活检病理诊断采用盲法。对汇管区和小叶内病变的各项参数进行半定量评分,分为4个严重程度等级。对所有汇管区进行形态计量学测量。与27例正常对照者相比,未经治疗的慢性活动性肝炎、肝硬化和原发性胆汁性肝硬化患者血清Col 1-3浓度显著升高,而慢性持续性肝炎和脂肪肝患者血清Col 1-3浓度无明显升高。汇管区形态计量学测量面积与Col 1-3血浆水平显著相关。在半定量评估的汇管区病变中,成纤维细胞数量与Col 1-3水平关系最为密切;Col 1-3水平与小叶内病变无相关性。这些数据表明,血清Col 1-3水平可可靠地反映肝纤维化的活动度和程度,在慢性肝病患者的随访中与肝活检一样具有重要价值。

相似文献

1
The N-terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease.血清中III型胶原蛋白的N端前肽反映了慢性肝病患者的纤维化活动和程度。
Hepatology. 1984 Sep-Oct;4(5):830-4. doi: 10.1002/hep.1840040505.
2
Long-term follow-up of serum N-terminal propeptide of collagen type III levels in patients with chronic liver disease.慢性肝病患者血清III型前胶原氨基端前肽水平的长期随访
Hepatology. 1984 Sep-Oct;4(5):835-8. doi: 10.1002/hep.1840040506.
3
Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis.评估血清层粘连蛋白P1、Ⅲ型前胶原肽和N-乙酰-β-葡萄糖苷酶用于监测肝纤维化活动度。
Hepatogastroenterology. 1989 Dec;36(6):506-10.
4
Comparison of assays for N-amino terminal propeptide of type III procollagen in chronic hepatitis C by using receiver operating characteristic analysis.应用接受者操作特征分析比较慢性丙型肝炎中III型前胶原N端前肽的检测方法
Eur J Gastroenterol Hepatol. 1999 Aug;11(8):827-31. doi: 10.1097/00042737-199908000-00003.
5
Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis. Relationship to liver histology and conventional liver tests.慢性肝炎患者血清I型胶原蛋白和III型前胶原N端肽。与肝脏组织学及传统肝功能检查的关系。
J Hepatol. 1991 Mar;12(2):139-44. doi: 10.1016/0168-8278(91)90929-6.
6
Procollagen-type III-peptide serum concentrations in chronic persistent and chronic active hepatitis and in cirrhosis of the liver and their diagnostic value.慢性持续性肝炎、慢性活动性肝炎及肝硬化患者血清Ⅲ型前胶原肽浓度及其诊断价值。
Z Gastroenterol. 1982 Dec;20(12):738-43.
7
Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C.原发性胆汁性肝硬化和慢性丙型病毒性肝炎中Ⅲ型前胶原氨基端前肽与透明质酸血清水平及组织学纤维化的关系
J Hepatol. 1994 Mar;20(3):388-93. doi: 10.1016/s0168-8278(94)80013-8.
8
Serum type I collagen and N-terminal peptide of type III procollagen in patients with alcoholic liver disease: relationship to liver histology.酒精性肝病患者血清I型胶原蛋白和III型前胶原N端肽:与肝脏组织学的关系
Alcohol Clin Exp Res. 1992 Apr;16(2):342-6. doi: 10.1111/j.1530-0277.1992.tb01388.x.
9
[Determination of serum procollagen-III peptide in chronic liver diseases. Clinical usefulness].[慢性肝病中血清Ⅲ型前胶原肽的测定。临床应用价值]
Minerva Med. 1992 Nov;83(11):715-20.
10
Procollagen-type III peptide serum concentrations in alcoholic and non-alcoholic liver disease.酒精性和非酒精性肝病中III型前胶原肽血清浓度
Ric Clin Lab. 1985 Apr-Jun;15(2):167-71. doi: 10.1007/BF03029835.

引用本文的文献

1
Advancements in metabolic-associated steatotic liver disease research: Diagnostics, small molecule developments, and future directions.代谢相关脂肪性肝病研究进展:诊断、小分子药物研发及未来方向。
Hepatol Res. 2024 Mar;54(3):222-234. doi: 10.1111/hepr.14008. Epub 2024 Jan 22.
2
Autoantibody Positivity Has No Impact on Histological Parameters in Nonalcoholic Fatty Liver Diseases.自身抗体阳性对非酒精性脂肪性肝病的组织学参数无影响。
J Clin Exp Hepatol. 2023 Sep-Oct;13(5):730-735. doi: 10.1016/j.jceh.2023.03.005. Epub 2023 Mar 17.
3
Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease.
儿童非酒精性脂肪性肝病中的无创生物标志物
World J Hepatol. 2023 May 27;15(5):609-640. doi: 10.4254/wjh.v15.i5.609.
4
Nonalcoholic Fatty Liver Disease-A Concise Review of Noninvasive Tests and Biomarkers.非酒精性脂肪性肝病——非侵入性检测与生物标志物的简要综述
Metabolites. 2022 Nov 5;12(11):1073. doi: 10.3390/metabo12111073.
5
High Compliance to Mediterranean Diet Associates with Lower Platelet Activation and Liver Collagen Deposition in Patients with Nonalcoholic Fatty Liver Disease.高依从地中海饮食与非酒精性脂肪性肝病患者血小板活化和肝胶原沉积降低相关。
Nutrients. 2022 Mar 12;14(6):1209. doi: 10.3390/nu14061209.
6
A 3D primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates.一种用于临床药物候选物疗效测试的非酒精性脂肪性肝炎的三维原代人源细胞体外模型。
Sci Rep. 2021 Nov 23;11(1):22765. doi: 10.1038/s41598-021-01951-7.
7
Antioxidant effects of aqueous extract of Salep on Paraquat-induced rat liver injury.药蜀葵水提取物对百草枯诱导的大鼠肝损伤的抗氧化作用。
World J Hepatol. 2017 Feb 8;9(4):209-216. doi: 10.4254/wjh.v9.i4.209.
8
Evaluation of Fucosylated Haptoglobin and Mac-2 Binding Protein as Serum Biomarkers to Estimate Liver Fibrosis in Patients with Chronic Hepatitis C.评估岩藻糖化触珠蛋白和Mac-2结合蛋白作为血清生物标志物用于估计慢性丙型肝炎患者肝纤维化的情况。
PLoS One. 2016 Mar 22;11(3):e0151828. doi: 10.1371/journal.pone.0151828. eCollection 2016.
9
The effects of low-intensity laser therapy on hepatic ischemia-reperfusion injury in a rat model.低强度激光疗法对大鼠模型肝缺血再灌注损伤的影响。
Lasers Med Sci. 2014 Nov;29(6):1887-93. doi: 10.1007/s10103-014-1603-7. Epub 2014 Jun 7.
10
CD4+CD25+Foxp3+ regulatory T cells contribute in liver fibrosis improvement with interferon alpha.CD4+CD25+Foxp3+ 调节性 T 细胞有助于干扰素 α 改善肝纤维化。
Inflammation. 2013 Dec;36(6):1374-82. doi: 10.1007/s10753-013-9677-0.